REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $14,671 | +20.4% | 378 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $12,183 | +12.4% | 378 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $10,842 | +3.6% | 378 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $10,464 | +3.5% | 378 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $10,112 | +23.5% | 378 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $8,188 | +718.8% | 378 | +417.8% | 0.00% | – |
Q3 2022 | $1,000 | – | 73 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |